Evidence map›Paper›PMID 29768505›Full record

ArticlePloS one2018

Multi-site evaluation of the LN34 pan-lyssavirus real-time RT-PCR assay for post-mortem rabies diagnostics.

Crystal M Gigante, Lisa Dettinger, James W Powell, Melanie Seiders, Rene Edgar Condori Condori, Richard Griesser, Kenneth Okogi, Maria Carlos, Kendra Pesko, Mike Breckenridge and 26 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Imported Human Rabies - Kentucky and Ohio, 2024.MMWR. Morbidity and mortality weekly report · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 13 institutions in 7 countries.

Crystal M GigantePoxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID 0000-0002-2169-7156
Lisa DettingerBureau of Laboratories, Pennsylvania Department of Health, Exton, Pennsylvania, United States of America.
James W PowellRabies Unit, Wisconsin State Laboratory of Hygiene, Madison, Wisconsin, United States of America.
Melanie SeidersBureau of Laboratories, Pennsylvania Department of Health, Exton, Pennsylvania, United States of America.
Rene Edgar Condori CondoriPoxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Richard GriesserRabies Unit, Wisconsin State Laboratory of Hygiene, Madison, Wisconsin, United States of America.
Kenneth OkogiRabies Laboratory, Center for Zoonotic and Vectorborne Diseases, Maryland Department of Health, Baltimore, Maryland, United States of America.
Maria CarlosRabies Laboratory, Center for Zoonotic and Vectorborne Diseases, Maryland Department of Health, Baltimore, Maryland, United States of America.
Kendra PeskoScientific Laboratory Division, New Mexico Department of Health, Santa Fe, New Mexico, United States of America.
Mike BreckenridgeScientific Laboratory Division, New Mexico Department of Health, Santa Fe, New Mexico, United States of America.
Edson Michael M SimonSpecial Pathogens Laboratory, Department of Health, Research Institute for Tropical Medicine, Alabang Muntinlupa City, Manila, Philippines.
Maria Yna Joyce V ChuSpecial Pathogens Laboratory, Department of Health, Research Institute for Tropical Medicine, Alabang Muntinlupa City, Manila, Philippines.
April D DavisRabies Laboratory, Wadsworth Center, New York State Department of Health, Albany, New York, United States of America.
Scott J BruntRabies Laboratory, Wadsworth Center, New York State Department of Health, Albany, New York, United States of America.
Lillian OrciariPoxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Pamela YagerPoxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
William C CarsonPoxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Claire HartlogePoxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Jeremiah T SalikiAthens Veterinary Diagnostic Laboratory, University of Georgia, Athens, Georgia, United States of America.
Susan SanchezAthens Veterinary Diagnostic Laboratory, University of Georgia, Athens, Georgia, United States of America.ORCID 0000-0002-2438-5983
Mojgan DeldariCalifornia Department of Public Health, Sacramento, California, United States of America.
Kristina HsiehCalifornia Department of Public Health, Sacramento, California, United States of America.
Ashutosh WadhwaPoxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Kimberly WilkinsPoxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Veronica Yung PeredoRabies section, Viral Disease, Public Health Institute of Chile, Santiago, Chile.ORCID 0000-0001-8376-5372
Patricia RabideauPublic Health Command Europe, Laboratory Sciences, Biological Analysis Division, Kirchberg Kaserne, Landstuhl, Germany.
Nina GruhnPublic Health Command Europe, Laboratory Sciences, Biological Analysis Division, Kirchberg Kaserne, Landstuhl, Germany.
Rolain CadetMinistère de l'Agriculture, Port-au-Prince, Haiti.
Shrikrishna IsloorOIE Twinned KVAFSU-CVA-Crucell Rabies Diagnostic Laboratory, Deptartment of Veterinary Microbiology, Veterinary College, KVAFSU, Hebbal, Bangalore, India.
Sujith S NathOIE Twinned KVAFSU-CVA-Crucell Rabies Diagnostic Laboratory, Deptartment of Veterinary Microbiology, Veterinary College, KVAFSU, Hebbal, Bangalore, India.
Tomy JosephAnimal Health Centre, Ministry of Agriculture, Abbotsford, British Columbia, Canada.
Jinxin GaoPoxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Ryan WallacePoxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Mary ReynoldsPoxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Victoria A OlsonPoxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Yu LiPoxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID 0000-0001-8815-6816
Centers for Disease Control and Prevention · USCalifornia Department of Public Health · USDepartment of Health · PHKarnataka Veterinary Animal and Fisheries Sciences University · INLandstuhl Regional Medical Center · DEMaryland Department of Health · USNew Mexico Department of Health · USNew York State Department of Health · USPennsylvania Department of Health · USUniversity of Georgia · USInstituto de Salud Pública de Chile · CLMinistry of Agriculture · CAMinistry of Agriculture Natural Resources and Rural Development · HT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rabies is a fatal zoonotic disease that requires fast, accurate diagnosis to prevent disease in an exposed individual. The current gold standard for post-mortem diagnosis of human and animal rabies is the direct fluorescent antibody (DFA) test. While the DFA test has proven sensitive and reliable, it requires high quality antibody conjugates, a skilled technician, a fluorescence microscope and diagnostic specimen of sufficient quality. The LN34 pan-lyssavirus real-time RT-PCR assay represents a strong candidate for rabies post-mortem diagnostics due to its ability to detect RNA across the diverse Lyssavirus genus, its high sensitivity, its potential for use with deteriorated tissues, and its simple, easy to implement design. Here, we present data from a multi-site evaluation of the LN34 assay in 14 laboratories. A total of 2,978 samples (1,049 DFA positive) from Africa, the Americas, Asia, Europe, and the Middle East were tested. The LN34 assay exhibited low variability in repeatability and reproducibility studies and was capable of detecting viral RNA in fresh, frozen, archived, deteriorated and formalin-fixed brain tissue. The LN34 assay displayed high diagnostic specificity (99.68%) and sensitivity (99.90%) when compared to the DFA test, and no DFA positive samples were negative by the LN34 assay. The LN34 assay produced definitive findings for 80 samples that were inconclusive or untestable by DFA; 29 were positive. Five samples were inconclusive by the LN34 assay, and only one sample was inconclusive by both tests. Furthermore, use of the LN34 assay led to the identification of one false negative and 11 false positive DFA results. Together, these results demonstrate the reliability and robustness of the LN34 assay and support a role for the LN34 assay in improving rabies diagnostics and surveillance.

Indexed as

RabiesAnimalsDiagnosisHumansLyssavirusReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionRNA, ViralRNA, Viral

Identifiers

PMID29768505
PMCPMC5955534
OpenAlexW2804722407

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.